LifeStance Health Expects 2024 Revenue Of $1.2B-$1.242B (Prior $1.19B-$1.24B) Vs $1.22B Est; Sees Adjusted EBITDA Of $90M-$100M
Portfolio Pulse from Benzinga Newsdesk
LifeStance Health has raised its 2024 revenue guidance to $1.2B-$1.242B, up from the prior $1.19B-$1.24B, and expects adjusted EBITDA of $90M-$100M. The company also anticipates positive free cash flow for the full year. For Q3 2024, LifeStance projects revenue of $290M-$310M and adjusted EBITDA of $15M-$21M.
August 08, 2024 | 10:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeStance Health has raised its 2024 revenue guidance to $1.2B-$1.242B and expects adjusted EBITDA of $90M-$100M. The company also anticipates positive free cash flow for the full year.
The raised revenue and EBITDA guidance indicates stronger financial performance than previously expected, which is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100